Literature DB >> 10562541

An unstable transmembrane segment in the cystic fibrosis transmembrane conductance regulator.

M Tector1, F U Hartl.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel with 12 membrane-spanning sequences, undergoes inefficient maturation in the endoplasmic reticulum (ER). Potentially charged residues in transmembrane segments may contribute to this defect in biogenesis. We demonstrate that transmembrane segment 6 of CFTR, which contains three basic amino acids, is extremely unstable in the lipid bilayer upon membrane insertion in vitro and in vivo. However, two distinct mechanisms counteract this anchoring deficiency: (i) the ribosome and the ER translocon co-operate to prevent transmembrane segment 6 from passing through the membrane co- translationally; and (ii) cytosolic domains of the ion channel post-translationally maintain this segment of CFTR in a membrane-spanning topology. Although these mechanisms are essential for successful completion of CFTR biogenesis, inefficiencies in their function retard the maturation of the protein. It seems possible that some of the disease-causing mutations in CFTR may reduce the efficiency of proper membrane anchoring of the protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562541      PMCID: PMC1171692          DOI: 10.1093/emboj/18.22.6290

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  12 in total

1.  A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide.

Authors:  M M Hämmerle; A A Aleksandrov; X B Chang; J R Riordan
Journal:  Glycoconj J       Date:  2000-11       Impact factor: 2.916

2.  Integration of Shaker-type K+ channel, KAT1, into the endoplasmic reticulum membrane: synergistic insertion of voltage-sensing segments, S3-S4, and independent insertion of pore-forming segments, S5-P-S6.

Authors:  Yoko Sato; Masao Sakaguchi; Shinobu Goshima; Tatsunosuke Nakamura; Nobuyuki Uozumi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Side chain and backbone contributions of Phe508 to CFTR folding.

Authors:  Patrick H Thibodeau; Chad A Brautigam; Mischa Machius; Philip J Thomas
Journal:  Nat Struct Mol Biol       Date:  2004-12-26       Impact factor: 15.369

4.  The chemical chaperone CFcor-325 repairs folding defects in the transmembrane domains of CFTR-processing mutants.

Authors:  Tip W Loo; M Claire Bartlett; Ying Wang; David M Clarke
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

Review 5.  Biogenesis of CFTR and other polytopic membrane proteins: new roles for the ribosome-translocon complex.

Authors:  H Sadlish; W R Skach
Journal:  J Membr Biol       Date:  2004-12       Impact factor: 1.843

Review 6.  Mechanisms for quality control of misfolded transmembrane proteins.

Authors:  Scott A Houck; Douglas M Cyr
Journal:  Biochim Biophys Acta       Date:  2011-11-11

7.  Harmonizing Experimental Data with Modeling to Predict Membrane Protein Insertion in Yeast.

Authors:  Christopher J Guerriero; Yessica K Gomez; Grant J Daskivich; Karl-Richard Reutter; Andrew A Augustine; Kurt F Weiberth; Kunio Nakatsukasa; Michael Grabe; Jeffrey L Brodsky
Journal:  Biophys J       Date:  2019-07-16       Impact factor: 4.033

8.  Mutations at arginine 352 alter the pore architecture of CFTR.

Authors:  Guiying Cui; Zhi-Ren Zhang; Andrew R W O'Brien; Binlin Song; Nael A McCarty
Journal:  J Membr Biol       Date:  2008-04-18       Impact factor: 1.843

Review 9.  Lipid-dependent membrane protein topogenesis.

Authors:  William Dowhan; Mikhail Bogdanov
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

10.  The ER membrane protein complex interacts cotranslationally to enable biogenesis of multipass membrane proteins.

Authors:  Matthew J Shurtleff; Daniel N Itzhak; Jeffrey A Hussmann; Nicole T Schirle Oakdale; Elizabeth A Costa; Martin Jonikas; Jimena Weibezahn; Katerina D Popova; Calvin H Jan; Pavel Sinitcyn; Shruthi S Vembar; Hilda Hernandez; Jürgen Cox; Alma L Burlingame; Jeffrey L Brodsky; Adam Frost; Georg Hh Borner; Jonathan S Weissman
Journal:  Elife       Date:  2018-05-29       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.